Global Single Use Products in Biopharmaceuticals Market, by Product Type {(Work Equipment [Flask, Containers, Syringes, Pipettes tips, Centrifuge tubes, Hand Gloves, Face Mask, Filters, Tubes, Others]), by Apparatus (Single Use Bioreactor, Isolators, Membrane Valves, Canister, Chromatography Systems, Filtration Systems, Mixing Systems, and Others)}, by End User (Pharmaceutical Companies, Biotechnology Companies and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,821.2 million in 2021 and is expected to exhibit a CAGR of 16.7% during the forecast period (2021-2028).
Market players are indulged in receiving drug approvals from the regulatory authorities for the single use products, which is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on July 22, 2021, Becton, Dickinson and Company which multinational medical technology company has received approval from the U.S. Food and Drug Administration (FDA) for vacutainer plus citrate plasma tubes, which is used for collection of blood to store, or transport or testing for identification of coagulopathy and also for testing COVID-19.
The increasing research and development activities by the market players for single use products for pharmaceutical is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on March 24, 2021, GEA Group, a supplier of pharmaceutical services introduced single use kytero separator, which is designed for harvesting fermentation broths and cell cultures. This separator has capacity of increasing maximum yield, gentle product handling and high separation efficiency, and helps in reducing the amount of production time.
Global Single Use Products in Biopharmaceuticals Market- Impact of Coronavirus (COVID – 19) Pandemic
The coronavirus disease (COVID-19) pandemic is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period owing to increasing manufacturing of vaccines. For instance, On October 19, 2021, The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has released data about the production of COVID-19 vaccine, which stated that globally the production output of COVID-19 dose will pass 12 billion in year 2021. And the production may double as per requirement of COVID-19 outbreak at all over the globe.
Increasing research and development activities for using single use products in pharmaceutical processing by the market players is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, In September 2018, Merck, a pharmaceutical company, Published study a case study on Complete Single-Use ADC Technology from Development through Scale-up where challenges of single use manufacturing for antibody drug conjugates (ADCs) were mentioned, the study states that Production featured longer processing at a higher temperature than is typical of ADC manufacture, placing the process at higher than normal risk for bio burden growth.
Browse 37 Market Data Tables and 40 Figures spread through 196 Pages and in-depth TOC on Global Single Use Products in Biopharmaceuticals Market, by Product Type {(Work Equipment [Flask, Containers, Syringes, Pipettes tips, Centrifuge tubes, Hand Gloves, Face Mask, Filters, Tubes, Others]), by Apparatus (Single Use Bioreactor, Isolators, Membrane Valves, Canister, Chromatography Systems, Filtration Systems, Mixing Systems, and Others)}, by End User (Pharmaceutical Companies, Biotechnology Companies and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the global single use products in biopharmaceuticals market, click the link below:
The increasing awareness program by market players is expected to drive growth of the global single use products in biopharmaceuticals market, over the forecast period. For instance, on October 6, 2021, Entegris which is American provider of products and systems that purify, protect, and transport critical materials used in the semiconductor device fabrication process conducted 10th annual Merck Single-Use Manufacturing Symposium virtual conference that includes attendees from Merck’s global Single-Use Network (SUN) community. The aim of this virtual conference was on COVID-19, quick implementation and scaling, streamlining, life cycle management and supply chain robustness, responsible consumption, designing safety, and overcoming challenges with new single-use technologies are all topics covered at this year's conference about single-use technologies (SUTs).
Key Takeaways of the Global Single Use Products in Biopharmaceuticals Market:
- The global single use products in biopharmaceuticals market is expected to exhibit a CAGR of 16.7% over the forecast period (2021-2028), owing to growth in prominent markets, especially in Europe. Moreover, North America region accounted for major market share in 2020.
- Increasing involvement of regulatory authorities for advanced product by the market players and research institutes is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on November 22, 2021, the U.S. Food and Drug Administration (FDA) released Medical Countermeasures Initiative (MCMi) for Advanced Manufacturing, where requirement of innovative product is needed U.S.FDA mentioned such as facility such as rapid scale manufacturing, acceleration of therapy development, shorten the processing steps, and increase the manufacturing of product.
- Some of the major players operating in the global single use products in biopharmaceuticals market include Aber instruments, Adolf Kühner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf , GE Healthcare, Gemu GmbH, Merck, Avantor, Meissner , New Horizon Biotech ,PBS-Biotech, Xcellerex, and Single Use Support GmbH.
